About The Company - hldpharma

wp-singular,page-template,page-template-full_width,page-template-full_width-php,page,page-id-15284,wp-theme-bridge,theme-bridge,bridge-core-1.0.4,woocommerce-no-js,ajax_fade,page_not_loaded,,qode-title-hidden,columns-4,qode-product-single-tabs-on-bottom,qode-theme-ver-18.0.8,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-7.9,vc_responsive

About HLD Pharmaceuticals

Health. Life. Discovery.

Founded in 2016 in Asansol, West Bengal, India, HLD Pharmaceuticals was established with a vision to contribute to the pharmaceutical and healthcare industry through quality products, trusted relationships and continuous progress.

Our name, HLD, represents Health, Life & Discovery — three principles that reflect our commitment to better health, the value of human life and the exploration of new opportunities.

Our product portfolio includes pharmaceutical formulations such as tablets, syrups and soft gelatin capsules, along with medical equipment and related healthcare products. We work with suppliers and manufacturers to serve our customers while prioritising product quality, reliability and responsible business practices.

We believe that trust, transparency and long-term relationships are essential to building a responsible pharmaceutical business. Our focus is on meeting customer needs, strengthening partnerships and exploring opportunities for sustainable growth.

Our Founder & CEO

Partha Pratim Hazra — Founder & CEO

HLD Pharmaceuticals was founded by Partha Pratim Hazra in 2016. His entrepreneurial vision, determination and commitment to business development have helped shape the company’s journey.

As Founder & CEO, he leads the company’s strategic direction, explores new business opportunities and works towards building a stronger, forward-looking enterprise. His long-term vision includes exploring opportunities across the pharmaceutical value chain and related industries.

Our Vision

To build a trusted, forward-looking pharmaceutical enterprise that contributes to healthcare accessibility, responsible business practices and the sustainable development of the pharmaceutical industry.

Our Mission

To prioritise quality and reliability across our product portfolio.
To build lasting relationships with customers, suppliers and business partners.
To explore new ideas, technologies and pharmaceutical business opportunities.
To pursue sustainable growth with integrity and accountability.
To consider environmental responsibility and regulatory compliance in our business development.

Our Core Values

Health: Supporting better health and well-being.

Life: Recognising the value of every life.

Discovery: Exploring new ideas and opportunities for progress.

Trust: Building lasting relationships through transparency and reliability.

Responsibility: Pursuing growth with integrity and accountability.

Our Commitment

At HLD Pharmaceuticals, we believe meaningful progress comes from combining ambition with responsibility, quality with trust and innovation with purpose. We look forward to strengthening our partnerships, exploring new possibilities and creating lasting value for the people and businesses we serve.

HLD Pharmaceuticals — Founded on Vision. Driven by Discovery. Focused on the Future.

Partha Pratim Hazra, Founder and CEO of HLD Pharmaceuticals

CEO’s Message

Partha Pratim Hazra
Founder & CEO, HLD Pharmaceuticals

Since founding HLD Pharmaceuticals in 2016 in Asansol, West Bengal, my vision has been to build a trusted pharmaceutical enterprise driven by quality, integrity and continuous progress.

Healthcare is an evolving field, and I believe that trust, responsible business practices and strong partnerships are essential to long-term success. At HLD Pharmaceuticals, we aim to serve our customers by focusing on product quality, reliable relationships and a commitment to meeting the needs of the healthcare sector.

Looking ahead, we aspire to explore new opportunities, strengthen our business capabilities and contribute to the development of the pharmaceutical industry. We believe that sustainable growth comes from combining entrepreneurial ambition with responsibility towards our customers, partners and society.

Our journey is guided by three simple principles: Health, Life & Discovery. These values inspire us to keep learning, improving and building for the future.

Thank you to our customers, suppliers, partners and well-wishers for being part of our journey.

Partha Pratim Hazra
Founder & CEO
HLD Pharmaceuticals

At the same time an etiological indications are shifting towards the prevalence of lifestyle diseases over acute illness indicating a departure from age old dynamics in disease and treatment.

On the other hand there has been a paradigm shift in the use of innovative drugs to that of low-cost API drugs after the economic recession, thereby causing a positive impact on the overall growth of the API market. As per the industry observers India and China will be the major API hub in next decade. In order to avail ourselves with this change we have mulled well to integrate further into Active Pharmaceutical Ingredient (API) and High Potency Active Pharmaceutical Ingredient (HPAPI).

Demand of Drug Intermediates was always there and increasing further with the emergent of India as a major API player. So our final goal is a versatile Drug Intermediate production facility.

All the production facilities will be eco friendly and shall be built with a strong sense of social commitment.

For a considerable period we have produced a number of path breaking drugs production techniques not only for the benefit of our country but also a large section of suffering mankind of South East Asia. It also introduced a number of improvised techniques to produce industrial chemicals at much cheaper cost which liberated many an end user from the vagaries of finding the right producer.

For decades the Indian Pharmaceutical industry is a free flowing river of prosperity by the rich water watersheds of contribution from numberless personalities and institutions. It becomes the chief driving force of today’s international recognition of reverence. We at HLD Pharmaceuticals shall dreem our toil be accomplished if our endeavor can add few more droplets into that stream.

Manufacturing Facilities

The Company envisages of an integrated manufacturing process for this project. To start with we shall establish an international class fixed dosage pharmaceutical manufacturing facility. That facility shall house production unit for tablets, capsules, oral liquid, Ointment and Parenteral for both the Beta-Lactam and non Beta-Lactum group.

In the second phase of integration we shall go for multiline Active Pharmaceutical Ingredient (API) plant with versatile process capacity. This type of industry has almost no presence in the Eastern India. Once commissioned it will not only help our plant in the input provision but also other Pharmaceutical houses in this region shall be hugely benefitted.

In the third phase we are envisaging to put plant for essential and import substitute Drug Intermediates. This will complete the backward integration of our production plan.